These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34780520)

  • 1. Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus.
    Sudadech P; Roytrakul S; Kaewprasert O; Sirichoat A; Chetchotisakd P; Kanthawong S; Faksri K
    PLoS One; 2021; 16(11):e0260003. PubMed ID: 34780520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.
    Fujiwara K; Uesugi F; Furuuchi K; Tanaka Y; Yoshiyama T; Saotome M; Ohta K; Mitarai S; Morimoto K
    Microbiol Spectr; 2021 Dec; 9(3):e0192821. PubMed ID: 34878300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
    Lee MC; Sun PL; Wu TL; Wang LH; Yang CH; Chung WH; Kuo AJ; Liu TP; Lu JJ; Chiu CH; Lai HC; Chen NY; Yang JH; Wu TS
    J Antimicrob Chemother; 2017 Oct; 72(10):2782-2786. PubMed ID: 29091186
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of four efflux pump inhibitors on the activities of clarithromycin against
    Teng TL; Shang YY; Huang HR; Chu NH; Chen ST
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 May; 45(5):468-474. PubMed ID: 35527462
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic Evolution of
    Li B; Guo Q; Mao Y; Zou Y; Zhang Y; Zhang Z; Chu H
    Can Respir J; 2020; 2020():7623828. PubMed ID: 32300380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A real-time PCR assay for rapid identification of inducible and acquired clarithromycin resistance in Mycobacterium abscessus.
    Sharma MK; La Y; Janella D; Soualhine H
    BMC Infect Dis; 2020 Dec; 20(1):944. PubMed ID: 33302900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Whole Genome Sequencing for Clarithromycin and Amikacin Resistance Prediction and Subspecies Identification of Mycobacterium abscessus.
    Realegeno S; Mirasol R; Garner OB; Yang S
    J Mol Diagn; 2021 Nov; 23(11):1460-1467. PubMed ID: 34454109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of drug-susceptibility patterns and gene sequences associated with clarithromycin and azithromycin resistance in
    Yoshida S; Tsuyuguchi K; Kobayashi T; Inoue Y; Suzuki K
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33570485
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
    Pryjma M; Burian J; Thompson CJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
    [No Abstract]   [Full Text] [Related]  

  • 11. Noncanonical mutations in ribosome nascent peptide exit tunnel confer clarithromycin resistance in Mycobacterium abscessus complex.
    Liao W; Wang X; Wang Y; Ma P; Chen K; Ge L; Yang X; Zeng S; Gao W; Zhang S; Wang H; Jia X; Luo T
    Int J Antimicrob Agents; 2024 Aug; 64(2):107223. PubMed ID: 38810940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin and Clarithromycin Show Synergy against
    Mukherjee D; Wu ML; Teo JWP; Dick T
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Performance Predicting Clarithromycin Resistance in
    Lipworth S; Hough N; Buchanan R; Smith EG; Robinson E; Alexander E; Peto T; Crook D; Walker T
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160290
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand.
    Ananta P; Kham-Ngam I; Chetchotisakd P; Chaimanee P; Reechaipichitkul W; Namwat W; Lulitanond V; Faksri K
    PLoS One; 2018; 13(11):e0208053. PubMed ID: 30496270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the
    Pryjma M; Burian J; Kuchinski K; Thompson CJ
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus.
    Li B; Ye M; Guo Q; Zhang Z; Yang S; Ma W; Yu F; Chu H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.
    Takei S; Ihara H; Togo S; Nakamura A; Fujimoto Y; Watanabe J; Kurokawa K; Shibayama K; Sumiyoshi I; Ochi Y; Iwai M; Okabe T; Chonan M; Misawa S; Ohsaka A; Takahashi K
    BMC Microbiol; 2020 Oct; 20(1):316. PubMed ID: 33076820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic correlates of clarithromycin susceptibility among isolates of the Mycobacterium abscessus group and the potential clinical applicability of a PCR-based analysis of erm(41).
    Carvalho NFG; Pavan F; Sato DN; Leite CQF; Arbeit RD; Chimara E
    J Antimicrob Chemother; 2018 Apr; 73(4):862-866. PubMed ID: 29272470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of tedizolid against the Mycobacterium abscessus complex.
    Compain F; Soroka D; Heym B; Gaillard JL; Herrmann JL; Dorchène D; Arthur M; Dubée V
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):186-189. PubMed ID: 29217419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.